Work

Effect of delayed consolidation durvalumab and timing of treatment on survival outcomes in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e18809

Authors: Samuel Xavier Stevens, Udit Nindra, Adel Shahnam, Victoria Jane Bray, Po Yee Yip, Tamiem Adam, Jenny HJ Lee, Michael J. Boyer, Adnan Nagrial, Steven Chuan-Hao Kao

Institutions: St George Hospital, Liverpool Hospital, Royal Prince Alfred Hospital, Westmead Hospital, Chris O’Brien Lifehouse, Blacktown & Mount Druitt Hospital, The University of Sydney

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286298007

Cites:

Cited by: 1

Related to: 10